Antioxidant properties |
92 obese patients |
Placebo-controlled randomized double-blind trial |
400 mg of garlic extract per day for 3 months |
Enhanced production of antioxidant |
[24] |
46 untrained boys |
Randomized controlled trial |
250 mg garlic capsule per day for 8 weeks |
Lowered oxidative stress and enhanced resistance and endurance during training |
[25] |
44 pregnant women |
Placebo-controlled randomized double-blind trial |
1 mg of allicin plus 400 mg garlic per day for 9 weeks |
Reduced oxidative stress |
[26] |
42 menopausal women |
Randomized double-blind controlled trial |
1200 μg allicin per day for one year |
Reduced oxidative stress |
[27] |
Anti-inflammatory properties |
120 healthy individuals |
Placebo-controlled randomized double-blind parallel intervention study |
2.56 g aged garlic extract (AGE) per day for 90 days |
Enhanced immune system functions |
[28] |
120 healthy subjects |
Randomized double-blind placebo-controlled nutrition intervention |
2.56 g aged garlic extract per day for 90 days |
Improved immune system function, less cold and flu symptoms |
[29] |
60 healthy volunteers |
Randomized controlled trial |
1 g to 3 g of garlic powder 6.0 and 24.0 h respectively |
Immunostimulatory effect |
[30] |
51 healthy but obese adults |
Placebo-controlled double-blind randomized trial |
3.6 g aged garlic extract per day for 6 weeks |
Reduced inflammation |
[31] |
Lipid lowering effects |
160 type 2 diabetic patients |
Randomized control trial |
500 mg of garlic powder and 1.1 mL of olive oil for 3 months |
Prevented dyslipidaemia |
[32] |
150 hyperlipidaemic patients |
Single-blind placebo-controlled study |
1 mg allicin and 400 mg garlic in tablet, twice daily for 6 weeks |
Lowered lipid levels |
[33] |
75 healthy adults |
Placebo-controlled randomized double-blind trial |
10.8 mg allicin (3 garlic cloves) per day for 12 weeks |
Lipid-lowering effects |
[34] |
70 diabetic patients with dyslipidaemia |
Placebo controlled randomized single-blind study |
Garlic tablet 300 mg, 2 times daily for 12 weeks |
Improvements in dyslipidaemia |
[35] |
Antidiabetic effects |
210 type 2 diabetes mellitus patients |
Placebo-controlled single-blind study |
Garlic tablet 300-1500 mg per day plus Metformin 500 mg twice a day for 24 weeks |
Reduced HbA1c and fasting blood glucose levels |
[36] |
Two 38-subject groups having diabetes |
Double blind trial |
750 mg capsule containing onion and garlic 20% (w/w), nettle leaf 20% (w/w), berry leaf 10% (w/w), walnut leaf 20% (w/w), fenugreek seed 20% (w/w), and cinnamon bark 10% (w/w), thrice daily for 12 weeks |
Decreased HbA1c and fasting blood sugar level. |
[37] |
Bone diseases |
80 overweight or obese postmenopausal women with knee osteoarthritis (OA) |
Placebo-controlled parallel-design randomized double-blind trial |
500 mg garlic tablet twice daily for 12 weeks |
Improved OA symptoms |
[38] |
76 overweight or obese postmenopausal women |
Placebo-controlled randomized double-blind parallel design trial |
1000 mg garlic tablet per day for 12 weeks |
Reduced pain severity |
[39] |
44 postmenopausal osteoporotic women |
Double-blind randomized controlled clinical trial |
2 garlic tablets per day for 8 months |
Immunomodulatory effects |
[27] |
Antimicrobial effects |
45 children |
Randomized double-blind controlled clinical trial |
2 mL garlic or garlic with lime formulation, used as mouth rinse, once a day for 2 weeks |
Economic and effective alternative to sodium fluoride mouth rinse |
[40] |
Antiviral effects on respiratory viral infections |
796 children |
Double-blind placebo-controlled randomized trial |
First stage Allicor 600 mg and second stage Allicor 300 mg tablets per day for 5 months |
Effective in the prevention of nonspecific acute respiratory infections, without any side effects |
[41] |
Anticancer effects |
57,560 men and women |
Comparison-based study |
One bulb of garlic per day for 9 years |
Reduced risk of colorectal adenoma |
[42] |
1,424 lung cancer cases and 4,543 healthy controls |
Population-based case control study |
Weekly administration of 8.4 g raw garlic or 33.4 g garlic components for 7 years |
Dose-dependent protective association between raw garlic and lung cancer |
[43] |
5,033 patients with gastric cancer (aged 35-74 years) |
Double-blind intervention study |
Synthetic allitridum 200 mg daily and 100 μg selenium every other day for 1 month per year, for a total of 3 years |
Protection from gastric cancer |
[44] |
3,365 H. pylori positive volunteers, with participants and risk for gastric cancer |
Placebo-controlled blinded randomized trial |
200 mg aged garlic extract and 1 mg steam distilled garlic oil 2, twice daily for 7.3 years |
Decreased incidence of gastric cancer and mortality |
[45] |
Cardioprotective effects |
157 postmenopausal asymptomatic women |
Placebo-controlled double-blind clinical trial |
Garlic herbal preparation containing 500 mg isoflavonoid for 12 months |
Suppression and prevention of atherosclerosis |
[46] |
92 obese patients |
Placebo-controlled randomized double-blind nutritional intervention |
Daily intake of 400 mg of garlic extract for 3 months |
Suppressed inflammation and improved endothelial biomarkers of cardiovascular problems |
[24] |
60 patients with mild hypercholesterolemia |
Randomized controlled trial |
6 g of aged black garlic twice a day for 12 weeks |
Enhanced cardioprotective effects, beyond gold standard medication |
[47] |
55 patients with metabolic syndrome |
Randomized double-blind study |
AGE 2400 mg daily for 52 weeks |
Decreased low attenuation plaque (LAP) formation in coronary arteries |
[48] |
51 coronary heart disease patients |
Placebo-controlled randomized double-blinded study |
150 mg Allicor garlic tablet 2 times per day for 12 months |
Significant reduction in cardiovascular risk, by 1.5-fold in men (p < 0.05) and 1.3-fold in women |
[49] |
Antihypertensive effects |
100 hyperlipidemic patients |
Randomized study |
Mixture of garlic and coriander, 2 g daily for 60 days |
Improved lipid parameters and reduced blood pressure |
[50] |
79 patients with uncontrolled systolic blood pressure |
Dose-response trial |
AGE 240/480/960 mg containing 0.6/1.2/2.4 mg of S-allylcysteine daily for 12 weeks |
Marked reduction in systolic blood pressure |
[51] |
41 moderately hypercholesterolemic patients |
Double-blind crossover study |
AGE 7.2 g daily for 10 months |
Reduced systolic and diastolic blood pressure |
[52] |